Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

  • Read more about Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

  • Read more about Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

  • Read more about Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

  • Read more about A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

  • Read more about Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

  • Read more about Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

  • Read more about A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

  • Read more about Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

  • Read more about Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Digital Cognition Study During Long-COVID

  • Read more about Digital Cognition Study During Long-COVID

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Current page 88
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA